Welcome to Critical Mass, Law.com’s weekly briefing on class actions and mass torts. Here’s what’s happening: Could some—or all—of the $289 million Roundup verdict get reversed? Labaton cuts a deal to end a lengthy over-billing inquiry, but the judge still has questions. And find out which law firm won last week’s defense verdict in the latest mesothelioma trial over Johnson & Johnson’s baby powder.

Send your feedback to [email protected], or find me on Twitter: @abronstadlaw.